Pathios Therapeutics Limited, a biotech company focused on the development of first-in-class therapies for cancer, has appointed Sumeet Ambarkhane, M.D., as Chief Medical Officer (CMO). A physician by training, Ambarkhane possesses more than 20 years of experience across academia and the biopharmaceutical industry in areas spanning clinical care, early through late-stage drug development, regulatory and commercialization. In his new role with Pathios, he will guide the advancement of the comp...